• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗非注射吸毒者中艾滋病毒流行的证据:系统评价。

Evidence of HIV epidemics among non-injecting drug users in Iran: a systematic review.

机构信息

Iranian Research Center for HIV/AIDS Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, Iran.

出版信息

Addiction. 2012 Nov;107(11):1929-38. doi: 10.1111/j.1360-0443.2012.03926.x. Epub 2012 Jun 15.

DOI:10.1111/j.1360-0443.2012.03926.x
PMID:22551085
Abstract

AIMS

In Iran, injecting drug users have been recognized as a high-risk group for HIV/AIDS for years. However, evidence of HIV epidemics in non-injecting drug users (non-IDUs) has also been found in recent years. The aim of this systematic review was to determine the prevalence of HIV in non-IDUs in Iran.

METHODS

International and regional databanks, including Pubmed, ISI, CINAHL, ASCI and IMEMR, as well as domestic databanks such as IranPsych, IranMedex SID and research reports were searched, and extensive personal contacts were made. All studies with HIV testing conducted between 1998 and 2007, which included non-IDU subjects, were gathered and their qualities were assessed. HIV prevalence was pooled for each gender and stratified to several categories. The prevalence of HIV in non-IDUs and IDUs was compared using pooled odds ratios in a fixed meta-analysis model.

RESULTS

Overall, 10 studies with 2275 non-IDU samples were included. Six of the studies were conducted in prison settings, two in treatment centres, one in a community setting and one in a shelter setting. Four studies were performed in Tehran, the capital city of Iran. The pooled HIV prevalence was 5.4% [95% confidence interval (CI) 3.7-7.4] after 2005, which was significantly higher than the prevalence before 2005 [1.6% (95% CI 1.0-2.3)]. IDUs were 4.36 (95% CI 2.63-7.24) times more likely to be infected with HIV than non-IDUs.

CONCLUSION

Iran is facing a major HIV epidemic among non-injecting illicit drug users, which necessitates an urgent preventive response.

摘要

目的

在伊朗,注射吸毒者多年来一直被认为是艾滋病毒/艾滋病的高危人群。然而,近年来也发现了非注射吸毒者(非 IDU)中艾滋病毒流行的证据。本系统评价的目的是确定伊朗非 IDU 中的艾滋病毒流行率。

方法

国际和地区数据库,包括 Pubmed、ISI、CINAHL、ASCI 和 IMEMR,以及国内数据库,如 IranPsych、IranMedex SID 和研究报告,都进行了搜索,并进行了广泛的个人联系。收集了 1998 年至 2007 年间进行的所有 HIV 检测研究,这些研究包括非 IDU 受试者,并对其质量进行了评估。按性别和分层为几个类别对 HIV 流行率进行了汇总。使用固定荟萃分析模型,对非 IDU 和 IDU 中的 HIV 流行率进行了比较。

结果

共有 10 项研究纳入了 2275 名非 IDU 样本。其中 6 项研究在监狱环境中进行,2 项在治疗中心进行,1 项在社区环境中进行,1 项在收容所环境中进行。有 4 项研究在伊朗首都德黑兰进行。2005 年后,HIV 总流行率为 5.4%(95%可信区间 3.7-7.4),明显高于 2005 年前的流行率[1.6%(95%可信区间 1.0-2.3)]。IDU 感染 HIV 的可能性是非 IDU 的 4.36 倍(95%可信区间 2.63-7.24)。

结论

伊朗正面临非注射吸毒者中艾滋病毒的大规模流行,这需要紧急采取预防措施。

相似文献

1
Evidence of HIV epidemics among non-injecting drug users in Iran: a systematic review.伊朗非注射吸毒者中艾滋病毒流行的证据:系统评价。
Addiction. 2012 Nov;107(11):1929-38. doi: 10.1111/j.1360-0443.2012.03926.x. Epub 2012 Jun 15.
2
HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007.伊朗注射吸毒者中的 HIV 流行率:1998-2007 十年间进行的研究的系统评价。
Int J Drug Policy. 2012 Jul;23(4):271-8. doi: 10.1016/j.drugpo.2011.09.002. Epub 2011 Oct 14.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.职业性HIV暴露后的抗逆转录病毒暴露后预防(PEP)。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and meta-analysis.巴西女性性工作者、吸毒者和男男性行为者中的艾滋病毒流行率:系统评价和荟萃分析。
BMC Public Health. 2010 Jun 7;10:317. doi: 10.1186/1471-2458-10-317.
7
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
8
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.
9
HIV prevalence among non-injecting people who use drugs and related factors in Iran: A systematic review and meta-analysis.伊朗非注射吸毒人群中的艾滋病毒流行率及相关因素:一项系统评价和荟萃分析。
Drug Alcohol Rev. 2022 Mar;41(3):666-676. doi: 10.1111/dar.13407. Epub 2021 Nov 16.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Association of , μ-opioid Receptor, and Cytochrome Genes with Methadone Dose in Iranian Male Addicts Under Methadone Therapy.伊朗接受美沙酮治疗的男性成瘾者中,μ-阿片受体和细胞色素基因与美沙酮剂量的关联。
Basic Clin Neurosci. 2024 Sep-Oct;15(5):703-712. doi: 10.32598/bcn.2023.2756.2. Epub 2024 Sep 1.
2
Prevalence of Tuberculosis among People Who Use Drugs in Iran: A Systematic Review and Meta-analysis.伊朗吸毒人群中的结核病患病率:系统评价与荟萃分析
Addict Health. 2023 Jul;15(3):219-227. doi: 10.34172/ahj.2023.1399. Epub 2023 Jul 29.
3
HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran: Findings from three consecutive national bio-behavioural surveys.
伊朗有 HIV 相关高危行为史的在押人员中的 HIV 检测:三项连续国家生物行为调查结果。
BMC Infect Dis. 2022 Dec 5;22(1):907. doi: 10.1186/s12879-022-07897-z.
4
Setting the policy agenda for the treatment of substance use disorders in Iran.设定伊朗药物使用障碍治疗的政策议程。
Harm Reduct J. 2022 Mar 15;19(1):27. doi: 10.1186/s12954-022-00612-w.
5
Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran.伊朗克尔曼注射吸毒人群队列研究中 HIV 和 HCV 发病率测量的失访比例和原因。
Subst Abuse Treat Prev Policy. 2021 Apr 1;16(1):29. doi: 10.1186/s13011-021-00368-9.
6
HIV in Iran: onset, responses, and future directions.伊朗的艾滋病毒:发病情况、应对措施和未来方向。
AIDS. 2021 Mar 15;35(4):529-542. doi: 10.1097/QAD.0000000000002757.
7
Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.伊朗吸毒人群中的乙型肝炎病毒感染:系统评价、荟萃分析和趋势分析。
Harm Reduct J. 2020 Oct 21;17(1):81. doi: 10.1186/s12954-020-00424-w.
8
Understanding the Reasons for Sharing Syringes or Needles to Inject Drugs: Conventional Content Analysis.了解共用注射器或针头注射毒品的原因:传统内容分析
Addict Health. 2020 Apr;12(2):98-108. doi: 10.22122/ahj.v12i2.255.
9
HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.伊朗注射毒品的艾滋病毒阴性人群中针对注射和性风险行为的艾滋病毒预防级联反应。
Int J Drug Policy. 2020 Oct;84:102868. doi: 10.1016/j.drugpo.2020.102868. Epub 2020 Jul 24.
10
The changing modes of human immunodeficiency virus transmission and spatial variations among women in a minority prefecture in southwest China: An exploratory study.中国西南部一个少数民族自治州女性中人类免疫缺陷病毒传播方式的变化及空间差异:一项探索性研究。
Medicine (Baltimore). 2020 Feb;99(6):e18776. doi: 10.1097/MD.0000000000018776.